The Advantages Of Autologous Stem Cell Transplants and Cryotherapy http://www.mslaw.edu In this excerpt from the Massachusetts School of Law's Educational Forum featuring Assistant Dean Diane Sullivan's journey through a ste... By: MSLawdotedu … Continue reading →

Bangalore, Dec 12 (IANS) Imran Qureshi, a 31-year-old Pakistani, underwent stem cell therapy for hip joint at a private hospital here. "Qureshi, a garment exporter from Karachi port city, has been treated for hip bone joint through stem cell therapy by our experts at the Bangalore Institute of Regenerative Medicine," Live 100 Hospital chairman H.N. Nagaraj told reporters Thursday. The disease, known as avascular necrosis in medical jargon, breaks the hip joint due to the cellular death of its bone tissues when blood supply is interrupted even in healthy people. "Though total hip replacement is suggested as one of the treatments for the rare disease, our institute has pioneered stem cell therapy, eliminating surgery," Nagaraj said, presenting Qureshi as one of his hospital's overseas beneficiaries. The treatment involves first extracting bone marrow of the patient for processing in a specialised laboratory at Pune, Maharashtra. Subsequently, the stem cells in the bone marrow are separated from red blood cells and blood plasma and injected into the hip joint of a patient under sterile conditions. "The transplanted stem cells restore hip joint function, which is lost due to damage to its cartilage. The stems cells also repair bone cells. As there is … Continue reading →

Current ratings for: Stem cell transplantation outcomes 'improved with new drug regime' Ratings require JavaScript to be enabled. New research suggests that outcomes for patients who have undergone stem cell transplants from unrelated or mismatched donors could be improved with the use of a drug called bortezomib, also known as velcade. This is according to a study presented at the annual meeting of the American Society of Hematology. Stem cell transplants are treatments carried out in an attempt to cure some cancers affecting the body's bone marrow, such as leukemia, lymphoma and myeloma. The treatment involves very high doses of chemotherapy (myeloablation) or whole body radiotherapy to clear a person's bone marrow and immune system of cancerous cells. After this process, the killed cells are replaced with healthy stem cells through a drip that flows into a vein. These stem cells can be from the patient's own body or from a donor - preferably a sibling. According to researchers from the Dana-Farber Cancer Institute who conducted the study, stem cells from unrelated or mismatched donors are likely to lead to worse patient outcomes following transplantation. These patients tend to have a higher mortality rate as a result of the treatment … Continue reading →

Phoenix, Arizona (PRWEB) December 11, 2013 The top Phoenix stem cell treatment clinic, Arizona Pain Stem Cell Institute, is now offering four stem cell therapies for arthritis. The treatments offered are very low risk and offered as an outpatient. For more information and scheduling on the regenerative medicine treatments offered, call (602) 507-6550. The Board Certified, Award Winning pain management doctors in Arizona provide either bone marrow, fat derived or amniotic stem cell injections. The fat or bone marrow is harvested from the patient, and immediately processed for injection into the target area. Since the material comes directly from the patient, the risks are exceptionally low. With regards to the amniotic derived injections, the fluid is obtained from consenting donors and processed at an FDA regulated lab. The treatment does not involve any fetal tissue, and contains a high concentration of stem cells, growth factors and anti-inflammatory factors. The additional treatment offered is platelet rich plasma therapy, known as PRP therapy for short. PRP therapy involves a simple blood draw from the patient, which is then centrifuged and spun down for 15 minutes to obtain a solution rich in platelets and growth factors. The PRP is then injected into the … Continue reading →

Contact Information Available for logged-in reporters only Newswise HOUSTON (Dec. 10, 2013) A first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School. The double-blinded, placebo-controlled studys purpose includes comparing the safety and effectiveness of banked cord blood to bone marrow stem cells. It is led by Charles S. Cox, Jr., M.D., the Childrens Fund, Inc. Distinguished Professor of Pediatric Surgery at the UTHealth Medical School and director of the Pediatric Trauma Program at Childrens Memorial Hermann Hospital. Co-principal investigator is Sean I. Savitz, M.D., professor and the Frank M. Yatsu, M.D., Chair in Neurology in the UTHealth Department of Neurology. The study builds on Cox extensive research studying stem cell therapy for children and adults who have been admitted to Childrens Memorial Hermann and Memorial Hermann-Texas Medical Center after suffering a traumatic brain injury (TBI). Prior research, published in the March 2010 issue of Neurosurgery, showed that stem cells derived from a patients own bone marrow were safely used in pediatric patients with TBI. Cox is also studying cord blood stem cell treatment for TBI in a separate … Continue reading →